Your Support
Sign Up for Newsletter

As advances in screening, molecular profiling, and systemic therapies accelerate, oncology care teams face increasing pressure to integrate new evidence into clinical decision-making. National and international professional forums, including the NCCN Annual Conference, serve an important role as venues for learning about how evolving evidence and expert consensus are shaping contemporary cancer care.

Taking place from March 26–29, 2026, for both in-person and virtual attendance, the NCCN Annual Conference is designed to improve patient outcomes by providing targeted education on guideline updates and key research findings, with practical strategies to facilitate the translation of evidence into clinical practice. The information is intended for everyone across the interdisciplinary care team. It may be particularly useful for those who practice in the community setting, featuring numerous treatment update recommendations that can be implemented immediately.

The conference programming centers on recent updates to NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), emerging therapeutic options, and the clinical implications of new toxicity and sequencing data, to help guide individualized treatment planning. Plenary sessions planned for the 2026 conference reflect several pressing priorities in oncology, including global approaches to cancer prevention and detection, as well as the increasing burden of early-onset malignancies.

The oncology community is facing a key challenge right now from the growing trend of cancer incidences in younger adults under 50-years-old. There has been a particularly sharp rise in incidence in breast, colorectal, kidney, and uterine cancers in people under 50. [1][2][3]

Sign Up for Newsletter
Your Support

Younger adults with cancer experience distinct clinical, biological, and psychosocial challenges throughout their cancer journey. Delays in diagnosis due to nonspecific symptoms and lack of screening, aggressive tumor biology, and a higher prevalence of hereditary cancer syndromes further complicate care. [3][4][5]

Advertisement #3
Foto 1.0  2025 NCCN Annual Conference session. Photo courtesy © 2025 – 2026 NCCN.  Used with permission

In addition to optimizing treatment strategies, oncology care teams must address issues such as fertility preservation, long-term treatment-related toxicities, mental health concerns, financial toxicity, and disparities in access to care.[6][7][8][9]Survivorship planning is often not tailored for the needs of this population, especially in community settings where specialized adolescent and young adult (AYA) programs are less available.[7][8]

The NCCN Annual Conference session will delve into current trends in AYA cancer incidence and some contributing factors. Speakers will also showcase ways to implement support services that will improve the health-related Quality of Life (hrQoL) for this patient population.

Additionally, new research on the distinct clinical profiles of younger and older patients at risk will be presented among the nearly 300 original posters on display during the conference. The top abstracts include studies on lung cancer screening adherence and feasibility, plus the real-world impact of MSI/MMR testing delays in colorectal cancer, where early detection and timely intervention have a big impact.

The conference sessions address many different cancer types, including breast, gastrointestinal, genitourinary, gynecologic, hematologic, lung, and skin cancer—as well as new, in-person sessions devoted to operational excellence in cancer care. The learning objectives are tailored to impart an understanding of the underlying evidence and expert consensus that drive guideline updates and best practices for care delivery. There will be time set aside for conversations to continue after many of the formal sessions, offering direct access to the leading experts behind the recommendations for further clarification of guideline development, interpretation of evidence, and areas of ongoing uncertainty.

As cancer care continues to evolve, oncology professionals must regularly reassess how emerging evidence, guideline updates, and patient-centered considerations intersect in daily practice. National forums such as the NCCN Annual Conference provide a setting for these discussions, reflecting broader efforts across the oncology community to address complexity, equity, and quality of care in the years ahead. Visit NCCN.org/conference to learn more.

__

Reference
[1] Koh B, Tan DJH, Ng CH, Fu CE, Lim WH, Zeng RW, Yong JN, Koh JH, Syn N, Meng W, Wijarnpreecha K, Liu K, Chong CS, Muthiah M, Luu HN, Vogel A, Singh S, Yeoh KG, Loomba R, Huang DQ. Patterns in Cancer Incidence Among People Younger Than 50 Years in the US, 2010 to 2019. JAMA Netw Open. 2023 Aug 1;6(8):e2328171. doi: 10.1001/jamanetworkopen.2023.28171. PMID: 37585204; PMCID: PMC10433086.
[2]. National Institutes of Health. Incidence rates of some cancer types have risen in people under age 50. News release. May 8, 2025. Online. Last accessed in September 2025.
[3] Sung H, et al. Colorectal cancer incidence trends in younger versus older adults. Lancet Oncol. 2025;26(6):e243-e252. doi:10.1016/S1470-2045(25)00123-7
[4] Dharwadkar P, Zaki TA, Murphy CC. Colorectal Cancer in Younger Adults. Hematol Oncol Clin North Am. 2022 Jun;36(3):449-470. doi: 10.1016/j.hoc.2022.02.005. Epub 2022 May 13. PMID: 35577711; PMCID: PMC9177054.
[5] Imyanitov EN, et al. Hereditary cancer syndromes. World J Clin Oncol. 2023 Feb 24;14(2):40-68. doi: 10.5306/wjco.v14.i2.40. PMID: 36908677; PMCID: PMC9993141.
[6] Su HI et al., Fertility Preservation in People With Cancer: ASCO Guideline Update, J Clin Oncol., 2025;43(12):1488-1515.https://doi.org/10.1200/JCO-24-02782.
[7] Berkman AM, Betts AC, Beauchemin M, Parsons SK, Freyer DR, Roth ME. Survivorship after adolescent and young adult cancer: models of care, disparities, and opportunities. J Natl Cancer Inst. 2024 Sep 1;116(9):1417-1428. doi: 10.1093/jnci/djae119. PMID: 38833671; PMCID: PMC11378318.
[8] Kirchhoff AC, et al. Access to Care for Adolescents and Young Adults With Cancer in the United States: State of the Literature. J Clin Oncol. 2024 Feb 20;42(6):642-652. doi: 10.1200/JCO.23.01027. Epub 2023 Nov 8. PMID: 37939320; PMCID: PMC11770896.
[9] NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Adolescent and Young Adult (AYA) Oncology. Available at: www.nccn.org.

Featured image courtesy © 2025 – 2026 NCCN.  Used with permission


DOI

Sign Up for Newsletter
Your Support

Advertisement #5